The board of directors of China Shineway Pharmaceutical Group Limited announced that Mr. Liu Tiejun ("Mr. Liu") has tendered his resignation as an executive director of the Company with effect from 1 November 2023 in order to devote more time to focus on his role as a vice president of Shineway Pharmaceutical Group Limited (an indirect wholly-owned subsidiary of the Company).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.89 HKD | +1.44% | +7.15% | +36.04% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+36.04% | 956M | |
+20.92% | 44.4B | |
+24.60% | 23.03B | |
+18.00% | 15.14B | |
+13.18% | 13.12B | |
+44.42% | 11.85B | |
-8.33% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.52B |
- Stock Market
- Equities
- 2877 Stock
- News China Shineway Pharmaceutical Group Limited
- China Shineway Pharmaceutical Group Limited Announces Resignation of Liu Tiejun as Executive Director, Effective 1 November 2023